The science behind medical cannabis

By : Global Rheumatology by PANLAR
09 December, 2021
views 598Views


This is an open-access article distributed by the terms of the Creative Common Attribution License (CC-BY NC-4). The use, distribution or reproduction in other forms is permitted, provided the original author(a) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with this terms.

The use of cannabis as medicine has undergone an important change in recent years, being currently evaluated as a therapeutic possibility for various pathologies, among them, of course, rheumatic diseases.

Today in Un café por la reumatología we will discuss the current state of medical cannabis, the scientific evidence concerning its use, patterns of use and clinical experience in the region.

Joining Carlo Vinicio Caballero, editor-in-chief of Global Rheumatology, and Diego Jaimes, will be Dario Scublinsky, a rheumatologist internist with a doctorate in medicine, former editor of the Revista Argentina de Reumatología and currently coordinator of rheumatology at Swiss Medical; as well as Paola Cubillos, Colombian physician from Universidad del Rosario, founding member of Procannacol, focused on the evidence-based use of medical cannabis; and Dr. Jaime Jaramillo Mejía, anesthesiologist, specialist in pain and palliative care.

enviar Envía un artículo